These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23728011)

  • 1. Renal insufficiency should be included in stroke risk scores.
    Barrios V; Escobar C
    Kidney Int; 2013 Jun; 83(6):1204-5. PubMed ID: 23728011
    [No Abstract]   [Full Text] [Related]  

  • 2. Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
    Olesen JB; Torp-Pedersen C
    Thromb Haemost; 2015 Jun; 113(6):1165-9. PubMed ID: 25743201
    [No Abstract]   [Full Text] [Related]  

  • 3. Stroke prevention in patients with atrial fibrillation and renal dysfunction.
    Kaatz S; Mahan CE
    Stroke; 2014 Aug; 45(8):2497-505. PubMed ID: 24968930
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rivaroxaban versus warfarin: results of the ROCKET study].
    Lipták J
    Ideggyogy Sz; 2012 Sep; 65(9-10):349-51. PubMed ID: 23126221
    [No Abstract]   [Full Text] [Related]  

  • 7. The introduction of novel oral anticoagulants in 2009 has been rightly heralded as a major therapeutic breakthrough.
    Pachinger O
    Wien Klin Wochenschr; 2014 Nov; 126(21-22):691. PubMed ID: 25398295
    [No Abstract]   [Full Text] [Related]  

  • 8. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 9. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 10. Stroke prevention versus bleeding risk in atrial fibrillation: a clinical dilemma.
    Hohnloser SH
    J Am Coll Cardiol; 2011 Jan; 57(2):181-3. PubMed ID: 21111556
    [No Abstract]   [Full Text] [Related]  

  • 11. Stroke prevention in atrial fibrillation patients.
    Marinigh R; Lip GY; Lane DA
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 16. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
    Deitelzweig S
    Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HAS-BLED shows bleeding risk in ischemic stroke and atrial fibrillation. But adjustments are needed for safer assessment, according to quality study].
    Alshakarchi J; Terént A
    Lakartidningen; 2012 Sep 19-26; 109(38):1670-2. PubMed ID: 23094397
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease.
    Turagam MK; Addepally NS; Velagapudi P
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.